In vitro and in vivo activities of arachidonic acid against Schistosoma mansoni and Schistosoma haematobium

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 8, 2010, Pages 3383-3389

  El Ridi, Rashika ^a   Aboueldahab, Marwa ^b   Tallima, Hatem ^a   Salah, Mohamed ^c   Mahana, Noha ^a   Fawzi, Samia ^b   Mohamed, Shadia H ^b   Fahmy, Omar M ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b Ain Shams University   (Egypt)

^c THEODOR BILHARZ RESEARCH INSTITUTE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CALCIUM CHLORIDE; ENZYME INHIBITOR; GW 4869; SPHINGOMYELIN PHOSPHODIESTERASE; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY REACTION; ARTICLE; ARTIFICIAL MILK; ATHLETE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CANADA; CHILD DEVELOPMENT; CONTROLLED STUDY; ENZYME ACTIVATION; MEMBRANE DAMAGE; MOUSE; MUSCLE GROWTH; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SINGLE DRUG DOSE; UNITED STATES;

ADMINISTRATION, ORAL; ANIMALS; ARACHIDONIC ACID; CRICETINAE; FEMALE; HUMANS; MALE; MESOCRICETUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, SCANNING; PARASITIC SENSITIVITY TESTS; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS HAEMATOBIA; SCHISTOSOMIASIS MANSONI; TREATMENT OUTCOME;

EID: 77955383443     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00173-10     Document Type: Article

References (36)

1. Botros, S. S., and J. L. Bennett. 2007. Praziquantel resistance. Expert Opin. Drug Discov. 2(Suppl. 1):S35-S40.
2. Brash, A. R. 2001. Arachidonic acid as a bioactive molecule. J. Clin. Invest. 107:1339-1345.
3. Burns, R. A., G. J. Wibert, D. A. Diersen-Schade, and C. M. Kelly. 1999. Evaluation of single-cell sources of docosahexaenoic acid and arachidonic acid: 3-month rat oral safety study with an in utero phase. Food Chem. Toxicol. 37:23-36.
4. Cioli, D., C. Valle, F. Angelucci, and A. E. Miele. 2008. Will new antischistosomal drugs finally emerge? Trends Parasitol. 24:379-382.
5. Contreras, F. X., L. Sánchez-Magraner, A. Alonso, and F. M. Goñi. 2010. Transbilayer (flip-flop) lipid motion and lipid scrambling in membranes. FEBS Lett. 584:1779-1786.
6. Contreras, F. X., V. Villar, A. Alonso, and F. M. Goñi. 2009. Ceramideinduced transbilayer (flip-flop) lipid movement in membranes. Methods Mol. Biol. 462:155-165.
7. Crawford, M. A., I. Golfetto, K. Ghebremeskel, Y. Min, T. Moodley, L. Poston, A. Phylactos, S. Cunnane, and W. Schmidt. 2003. The potential role for arachidonic and docosahexaenoic acids in protection against some central nervous system injuries in preterm infants. Lipids 38:303-315.
8. El Ridi, R., and H. Tallima. 2006. Equilibrium in lung schistosomula sphingomyelin breakdown and biosynthesis allows very small molecules, but not antibody, to access proteins at the host-parasite interface. J. Parasitol. 92:730-737. (Pubitemid 44435589)
9. Gnanasekar, M., A. M. Salunkhe, A. K. Mallia, Y. X. He, and K. Ramaswamy. 2009. Praziquantel affects the regulatory myosin light chain of Schistosoma mansoni. Antimicrob. Agents Chemother. 53:1054-1060.
10. Goñi, F. M., and A. Alonso. 2002. Sphingomyelinases: enzymology and membrane activity. FEBS Lett. 531:38-46.
11. Gryseels, B., K. Polman, J. Clerinx, and L. Kestens. 2006. Human schistosomiasis. Lancet 368:1106-1118.
12. Hannun, Y. A., and C. Luberto. 2000. Ceramide in the eukaryotic stress response. Trends Cell Biol. 10:73-80.
13. Harbige, L. S. 2003. Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids 38:323-341. (Pubitemid 36724289)
14. Hempenius, R. A., J. M. H. Van Delft, M. Prinsen, and B. A. R. Lina. 1997. Preliminary safety assessment of an arachidonic acid-enriched oil derived from Mortierella alpina: summary of toxicological data. Food Chem. Toxicol. 35:573-581.
15. Huwiler, A., T. Kolter, J. Pfeilschifter, and K. Sandhoff. 2000. Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim. Biophys. Acta 1485:63-99.
16. Keiser, J., J. Chollet, S. H. Xiao, J. Y. Mei, P. Y. Jiao, J. Utzinger, and M. Tanner. 2009. Mefloquine - an aminoalcohol with promising antischistosomal properties in mice. PLoS Negl. Trop. Dis. 3:e350.
17. Keiser, J., M. Vargas, and M. J. Doenhoff. 2010. Activity of artemether and mefloquine against juvenile and adult Schistosoma mansoni in athymic and immunocompetent NMRI mice. Am. J. Trop. Med. Hyg. 82:112-114.
18. Koskelo, E. K., K. Boswell, L. Carl, S. Lanoue, C. Kelly, and D. Kyle. 1997. High levels of dietary arachidonic acid triglyceride exhibit no subchronic toxicity in rats. Lipids 132:397-405.
19. Luberto, C., D. F. Hassler, P. Signorelli, Y. Okamoto, H. Sawai, E. Boros, D. J. Hazen-Martin, L. M. Obeid, Y. A. Hannun, and G. K. Smith. 2002. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase. J. Biol. Chem. 277:41128-41139.
20. Marchesini, N., C. Luberto, and Y. A. Hannun. 2003. Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism. J. Biol. Chem. 278:13775-13783.
21. Merrill, A. H., Jr. 2002. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J. Biol. Chem. 277:25843-25846.
22. Pica-Mattoccia, L., C. Valle, A. Basso, A. R. Troiani, F. Vigorosi, P. Liberti, A. Festucci, and D. Cioli. 2007. Cytochalasin D abolishes the schistosomicidal activity of praziquantel. Exp. Parasitol. 115:344-351.
23. Rao, B. G., and M. W. Spence. 1976. Sphingomyelinase activity at pH 7.4 in human brain and comparison to activity at pH 5.0. J. Lipid Res. 17:506-515.
24. Sayed, A. A., A. Simeonov, C. J. Thomas, J. Inglese, C. P. Austin, and D. L. Williams. 2008. Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nat. Med. 14:407-412.
25. Simopoulos, A. 2001. Evolutionary aspects of diet and essential fatty acids. World Rev. Nutr. Diet 88:18-27.
26. Smithers, S. R., and R. J. Terry. 1965. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology 55:695-700.
27. Steinmann, P., J. Keiser, R. Bos, M. Tanner, and J. Utzinger. 2006. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect. Dis. 6:411-425.
28. Tallima, H., and R. El Ridi. 2007. Praziquantel binds Schistosoma mansoni adult worm actin. Int. J. Antimicrob. Agents 29:570-575.
29. Tallima, H., M. Salah, and R. El Ridi. 2005. In vitro and in vivo effects of unsaturated fatty acids on Schistosoma mansoni and S. haematobium lungstage larvae. J. Parasitol. 91:1094-1102.
30. Tallima, H., and R. El Ridi. 2008. Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase is a lung-stage schistosomula surface membrane antigen. Folia Parasitol. 55:180-186.
31. Utzinger, J., S. Xiao, E. K. N'Goran, R. Bergquist, and M. Tanner. 2001. The potential of artemether for the control of schistosomiasis. Int. J. Parasitol. 31:1549-1562.
32. Wibert, G. J., R. A. Burns, D. A. Diersen-Schade, and C. M. Kelly. 1997. Evaluation of single cell sources of docosahexaenoic acid and arachidonic acid: a 4-week oral safety study in rats. Food Chem. Toxicol. 35:967-974.
33. Wiest, P. M., S. S. Kunz, and K. R. Miller. 1994. Activation of protein kinase C by phorbol esters disrupts the tegument of Schistosoma mansoni. Parasitology 109:461-468. (Pubitemid 24327396)
34. Xiao, S. H., and B. A. Catto. 1989. In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni. Antimicrob. Agents Chemother. 33:1557-1562.
35. Xiao, S., J. Utzinger, J. Chollet, Y. Endriss, E. K. N'Goran, and M. Tanner. 2000. Effect of artemether against Schistosoma haematobium in experimentally infected hamsters. Int. J. Parasitol. 30:1001-1006.
36. Zhou, L., and A. Nilsson. 2001. Sources of eicosanoid precursor fatty acid pools in tissues. J. Lipid Res. 42:1521-1542. (Pubitemid 33020085)